Update on the diagnosis and management of prostate cancer.
Early detection of prostate adenocarcinoma (prostate cancer) through screening tests such as a serum prostate-specific antigen (PSA) test and a digital rectal examination (DRE) enables primary care physicians and urologists to offer patients a broader choice of treatments that are also more likely to provide a cure. Whether men are being over treated or over diagnosed through the widespread use of screening tests remains controversial. This review aims to provide general practitioners with a better understanding of different prostate cancer tests that can be performed and to help them decide which patients should be referred to a urologist for an ultrasound-guided biopsy.
LaSpina
Mark
M
Department of Urology, State University of New York, Upstate Medical University, 750 East Adams Street, Syracuse, NY 31210, USA.
Haas
Gabriel P
GP
D001706:Biopsy; D002170:Canada / Q000453:epidemiology; D003131:Combined Modality Therapy / Q000379:methods; D003937:Diagnosis, Differential; D051517:Digital Rectal Examination / Q000379:methods; D019160:Endosonography / Q000379:methods; D006801:Humans; D008297:Male; D009017:Morbidity / Q000639:trends; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D017430:Prostate-Specific Antigen